These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19658287)

  • 1. [Platelet inhibition remains the second choice. "Anticoagulation should always be the goal" (interview by Dr. med. Jochen Aumiller)].
    Connolly S
    MMW Fortschr Med; 2009 Apr; 151(16):11. PubMed ID: 19658287
    [No Abstract]   [Full Text] [Related]  

  • 2. [ASS plus clopidogrel in contraindication for marcumar].
    Einecke D
    MMW Fortschr Med; 2009 Apr; 151(16):10-1. PubMed ID: 19658286
    [No Abstract]   [Full Text] [Related]  

  • 3. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 4. Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Healey JS
    Thromb Haemost; 2009 Nov; 102(5):912-3. PubMed ID: 19888528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
    Erdmann E
    Internist (Berl); 2006 Dec; 47(12):1295-7. PubMed ID: 17096154
    [No Abstract]   [Full Text] [Related]  

  • 6. If there's smoke, is there fire?
    Ferguson JJ
    Circulation; 2004 Mar; 109(12):1442-4. PubMed ID: 15051646
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
    Diener C
    MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
    Macdonald S
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):143-4. PubMed ID: 17588786
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
    Meinertz T
    Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764
    [No Abstract]   [Full Text] [Related]  

  • 11. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
    Einecke D
    MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acetylsalicylic acid in ischemic insult].
    Noth J
    Dtsch Med Wochenschr; 1998 Feb; 123(9):270. PubMed ID: 9524540
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin still best for clot prevention.
    Health News; 2006 Aug; 12(8):6. PubMed ID: 16913028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary and secondary prevention of stroke. Prevention is better than healing].
    Stiefelhagen P
    MMW Fortschr Med; 2004; 146 Suppl 1():12-7; quiz 18-9. PubMed ID: 15493414
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral anticoagulation in activated protein C resistance?].
    Stiegler H
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1619. PubMed ID: 9011491
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of anticoagulation in patients with bioprostheses.
    Gherli T; Colli A; Nicolini F
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
    [No Abstract]   [Full Text] [Related]  

  • 20. [More modest use in secondary prevention, risky in primary prevention].
    MMW Fortschr Med; 2006 Apr; 148(14):10-1. PubMed ID: 16669270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.